MedPath

Preterm infants knowledge on target height and outcome

Not Applicable
Completed
Conditions
ow birth weight Infants
Pregnancy and Childbirth
Low birth weight
Registration Number
ISRCTN80622320
Lead Sponsor
niversity Medical Center Groningen (UMCG) (The Netherlands)
Brief Summary

2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21324481 developmental delay results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22147746 behavioural and emotional problems results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22630341 demographics results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22778308 neonatal morbidity results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22945414 neuropsychological functioning results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23020259 developmental delay results 2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23525931 respiratory problems results 2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23968750 low socioeconomic status results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25189655 RSV infection results 2018 Results article in http://www.ncbi.nlm.nih.gov/pubmed/29579559 gross motor milestones results 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30266509 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31048855 results (added 15/01/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33596865/ results (added 26/02/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33780801/ (added 15/12/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
2125
Inclusion Criteria

All infants born before 36 completed weeks gestation in a well defined large region of the Netherlands in 2002 and 2003.

Exclusion Criteria

1. Major congenital malformations
2. Congenital infections

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eurodevelopment and growth
Secondary Outcome Measures
NameTimeMethod
o secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath